Pancreatic Cancer Research

ResearcherTianjin Nankai HospitalNo recent work listed

Shuai Qiu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7594-7619; OpenAlex author ID A5030318140. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 4

  1. Epigallocatechin-3-Gallate Decreases Hypoxia-Inducible Factor-1 in Pancreatic Cancer Cells. Co-author DOI 10.1142/s0192415x23500362↗
  2. Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states. Co-author DOI 10.1096/fj.202100121rrr↗
  3. Increased dietary fatty acids determine the fatty-acid profiles of human pancreatic cancer cells and their carrier's plasma, pancreas and liver. Co-author DOI 10.1507/endocrj.ej19-0429↗
  4. β-Pentagalloyl-Glucose Sabotages Pancreatic Cancer Cells and Ameliorates Cachexia in Tumor-Bearing Mice. Co-author DOI 10.1142/s0192415x19500356↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Wang · 3 shared papers, 2019–2023 · strength 0.45
  2. Lijuan Hu · 3 shared papers, 2019–2023 · strength 0.45
  3. Dapeng Zhang · 2 shared papers, 2021–2023 · strength 0.34
  4. Chuanshan Yao · 1 shared paper, 2021 · strength 0.13
  5. Jing Yang · 1 shared paper, 2019 · strength 0.11
  6. Lihua Cui · 1 shared paper, 2019 · strength 0.11
  7. Wencong Tian · 1 shared paper, 2020 · strength 0.11
  8. Ming Yu · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.